A PYMNTS Company

The Application of EU Competition Law in the Pharmaceutical Sector

By  |  September 10, 2012

 

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    The Application of EU Competition Law in the Pharmaceutical Sector by David W. Hull (Covington)

    ABSTRACT: If the Court of Justice follows the Advocate General’s advice and upholds the General Court’s judgment in AstraZeneca, this may result in increased enforcement aimed at various life cycle management strategies. The Commission’s current enforcement priority remains combatting practices that slow generic entry, particularly reverse-payment patent settlements. The Commission has shown a renewed interest in parallel trade, particularly dual-pricing arrangements in Spain.